The fact that both DMR7 and SKT82 showed a strong trend toward reducing tau pathology in the contralateral hippocampus might suggest that this isotype differences is not as critical to slowing the subsequent transmission of tau pathology to sites distant from the AD-tau injection site. Here, MAPT is linked to Alzheimer disease.